GGrantIndex
← Search

UCLA IRB # 06-04-016 "PHASE II TRIAL OF BEVACIZUMAB IN COMBINATION WITH TEMOZ

$11,677M01FY2007RRNIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →